Primary Hyperparathyroidism clinical trials
7 active trials name this condition. Describe your situation to see which ones you may be eligible for.
- Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
- Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors
- Parathyroidectomy and Mobility Study
- Parathyroid Tumor Clonal Status
- Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- Natural History Study of Parathyroid Disorders
- Patient Navigation to Improve Surgical Access in Primary Hyperparathyroidism
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Primary Hyperparathyroidism” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.